跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28 条关于
“Argobio”
全部
28
临床试验
5
药物
1
机构
5
资讯
17
8个月前
Enodia Therapeutics Secures €20.7M Seed Funding to Advance Novel Protein Degradation Platform Targeting SEC61 Translocon
去年
Elkedonia Raises €11.25 Million to Develop Novel Neuroplastogen Therapy for Treatment-Resistant Depression
去年
Enodia Therapeutics Launches with Novel Protein Degradation Platform Targeting Cancer and Inflammatory Diseases
9个月前
Laigo Bio Secures €11.5 Million to Advance Novel Protein Degradation Platform for Cancer and Autoimmune Diseases
5个月前
Laigo Bio Secures €17M in Oversubscribed Seed Round to Advance Novel Protein Degradation Platform
4个月前
Kurma Partners Closes Biofund IV at €215M, Fueling European Biotech Company Creation
2年前
OrsoBio Secures $67M for Obesity Drugs, Vor Bio's AML Therapy Shows Promise, and More
去年
AriBio and Arcera Forge $600 Million Partnership for Novel Alzheimer's Drug AR1001
去年
ProBio Opens 128,000-Square-Foot Gene Therapy Manufacturing Center in New Jersey
4个月前
ProBio Launches Viral Vector Packaging Test to Accelerate Cell and Gene Therapy Development
第 1 页,共 2 页
上一页
下一页